National Stroke Foundation

FDA Approved Drugs by Name
Company: Amgen

Search by brand name for drugs approved by the Food and Drug Administration (FDA) for sale in the United States. Each listing contains a brief description of the indication for use. Click on the drug name for a complete product profile, including general information, clinical trial results, side effects and manufacture information.

Aimovig (erenumab-aooe)

For the preventive treatment of migraine in adults

Blincyto (blinatumomab)

For the treatment of Philadelphia chromosome-negative relapsed /refractory B cell precursor acute lymphoblastic leukemia

Corlanor (ivabradine)

For the treatment of chronic heart failure

Evenity (romosozumab-aqqg)

For the treatment of osteoporosis in postmenopausal women at high risk for fracture

Imlygic (talimogene laherparepvec)

For the treatment of unresectable recurrent melanoma

INFERGEN (interferon alfacon-1)

Treatment for chronic hepatitis C virus


Injectable therapy for the treatment of rheumatoid arthritis


Treatment to decrease the chance of infection by febrile neutropenia in patients receiving chemotherapy


Treatment for slow white blood cell recovery following chemotherapy

Nplate (romiplostim)

For the treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura

Parsabiv (etelcalcetide)

For the treatment of secondary hyperparathyroidism in adults with chronic kidney disease on hemodialysis

Prolia (denosumab)

For the treatment of osteoporosis and bone loss in men and women

Repatha (evolocumab)

For the treatment of high cholesterol

Sensipar (cinacalcet)

For the treatment of secondary hyperparathyroidism and hypercalcemia in parathyroid carcinoma patients

Vectibix (panitumumab)

For the treatment of colorectal cancer

Xgeva (denosumab)

For the prevention of skeletal-related events in patients with bone metastases from solid tumors

Xgeva (denosumab)

For the treatment of giant cell tumor of bone